PRIDEVIN M1

Composition
Metformin 500 mg Prolonged Release +Glimepiride 1 mg SMART TABLETS
Pack: 15 tablets/strip
DOSAGE: 1 to 2 Tablets / Day
The real-world evidence in the Indian clinical setting Indicates that Glimepiride and Metformin fixed-dose combinations are widely used in the management in T2DM patients with comorbidities like hypertension, dyslipidemia and diabetes complications. Glimepiride and Metformin fixed-dose combinations are suitable for early as well as long-standing diabetes.
Indication:
- Not associated with hypoglycemia
- No Weight Gain
- Increased insulin sensitivity
- Beneficial effects on Lipid profile (HDL-LDL)
- Reduction in risk of stroke